Lancanshire, United Kingdom

Ali Raoof

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ali Raoof. Retrieved from https://idiyas.com/inventor/ali-raoof-qnzc5oty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ali Raoof

Introduction

Ali Raoof is a notable inventor based in Lancashire, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on new derivatives that have potential applications in treating chronic pain.

Latest Patents

Ali Raoof holds a patent for Triazine-oxadiazoles. This invention relates to new derivatives of formula (I), wherein the substituents are as defined in the specification. The patent also covers processes for the preparation of such derivatives, pharmaceutical compositions comprising these derivatives, and their use as a medicament for the treatment of chronic pain. He has 1 patent to his name.

Career Highlights

Ali Raoof is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on developing innovative solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Ali has collaborated with talented individuals such as Oliver Barker and Alexander Heifetz. These collaborations have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Ali Raoof's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of chronic pain.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…